CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter's five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Technological advancements in single-cell analysis products
3.5.1.2.Increase in adoption of personalized medicine for the screening and diagnostics of genetic disorders
3.5.2.Restraints
3.5.2.1.High cost of single-cell analysis products
3.5.2.2.Dearth of skilled professionals
3.5.3.Opportunities
3.5.3.1.Increasing funding in the research of single cell multiomics
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on the single cell multiomics market

CHAPTER 4:SINGLE CELL MULTIOMICS MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Single Cell Genomics
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Single Cell Proteomics
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Single Cell Transcriptomics
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
4.5.Single Cell Metabolomics
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

CHAPTER 5:SINGLE CELL MULTIOMICS MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Oncology
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Cell Biology
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.4.Neurology
5.4.1.Market size and forecast
5.4.2.Market analysis, by country
5.5.Others
5.5.1.Market size and forecast
5.5.2.Market analysis, by country

CHAPTER 6:SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE
6.1.Overview
6.1.1.Market size and forecast
6.2.Single-Cell Isolation and Dispensing
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by application
6.2.3.1.Oncology
6.2.3.1.1.Market size and forecast
6.2.3.2.Cell Biology
6.2.3.2.1.Market size and forecast
6.2.3.3.Neurology
6.2.3.3.1.Market size and forecast
6.2.3.4.Others
6.2.3.4.1.Market size and forecast
6.3.Single-Cell Analysis
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.3.3.Market size and forecast, by application
6.3.3.1.Oncology
6.3.3.1.1.Market size and forecast
6.3.3.2.Cell Biology
6.3.3.2.1.Market size and forecast
6.3.3.3.Neurology
6.3.3.3.1.Market size and forecast
6.3.3.4.Others
6.3.3.4.1.Market size and forecast

CHAPTER 7:SINGLE CELL MULTIOMICS MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Academic Institutes
7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country
7.3.Contract Research Organizations
7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country
7.4.Pharmaceutical and Biotech Companies
7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country

CHAPTER 8:SINGLE CELL MULTIOMICS MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country
8.2.2.1.U.S. Single cell multiomics market, by type
8.2.2.2.U.S. Single cell multiomics market, by application
8.2.2.3.U.S. Single cell multiomics market, by technique
8.2.2.4.U.S. Single cell multiomics market, by end user
8.2.2.5.Canada Single cell multiomics market, by type
8.2.2.6.Canada Single cell multiomics market, by application
8.2.2.7.Canada Single cell multiomics market, by application
8.2.2.8.Canada Single cell multiomics market, by end user
8.2.2.9.Mexico Single cell multiomics market, by type
8.2.2.10.Mexico Single cell multiomics market, by application
8.2.2.11.Mexico Single cell multiomics market, by application
8.2.2.12.Mexico Single cell multiomics market, by end user
8.2.3.North America market size and forecast, by type
8.2.4.North America market size and forecast, by application
8.2.5.North America market size and forecast, by technique
8.2.5.1.North America single-cell isolation and dispensing, by application
8.2.5.2.North America single-cell analysis, by application
8.2.6.North America market size and forecast, by end user
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country
8.3.2.1.Germany Single cell multiomics market, by type
8.3.2.2.Germany Single cell multiomics market, by application
8.3.2.3.Germany Single cell multiomics market, by application
8.3.2.4.Germany Single cell multiomics market, by end user
8.3.2.5.France Single cell multiomics market, by type
8.3.2.6.France Single cell multiomics market, by application
8.3.2.7.France Single cell multiomics market, by technique
8.3.2.8.France Single cell multiomics market, by end user
8.3.2.9.UK Single cell multiomics market, by type
8.3.2.10.UK Single cell multiomics market, by application
8.3.2.11.UK Single cell multiomics market, by technique
8.3.2.12.UK Single cell multiomics market, by end user
8.3.2.13.Italy Single cell multiomics market, by type
8.3.2.14.Italy Single cell multiomics market, by application
8.3.2.15.Italy Single cell multiomics market, by technique
8.3.2.16.Italy Single cell multiomics market, by end user
8.3.2.17.Spain Single cell multiomics market, by type
8.3.2.18.Spain Single cell multiomics market, by application
8.3.2.19.Spain Single cell multiomics market, by technique
8.3.2.20.Spain Single cell multiomics market, by end user
8.3.2.21.Rest of Europe Single cell multiomics market, by type
8.3.2.22.Rest of Europe Single cell multiomics market, by application
8.3.2.23.Rest of Europe Single cell multiomics market, by technique
8.3.2.24.Rest of Europe Single cell multiomics market, by end user
8.3.3.Europe market size and forecast, by type
8.3.4.Europe market size and forecast, by application
8.3.5.Europe market size and forecast, by technique
8.3.5.1.Europe single-cell isolation and dispensing, by application
8.3.5.2.Europe single-cell analysis, by application
8.3.6.Europe market size and forecast, by end user
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country
8.4.2.1.Japan Single cell multiomics market, by type
8.4.2.2.Japan Single cell multiomics market, by application
8.4.2.3.Japan Single cell multiomics market, by technique
8.4.2.4.Japan Single cell multiomics market, by end user
8.4.2.5.China Single cell multiomics market, by type
8.4.2.6.China Single cell multiomics market, by application
8.4.2.7.China Single cell multiomics market, by technique
8.4.2.8.China Single cell multiomics market, by end user
8.4.2.9.Australia Single cell multiomics market, by type
8.4.2.10.Australia Single cell multiomics market, by application
8.4.2.11.Australia Single cell multiomics market, by technique
8.4.2.12.Australia Single cell multiomics market, by end user
8.4.2.13.India Single cell multiomics market, by type
8.4.2.14.India Single cell multiomics market, by application
8.4.2.15.India Single cell multiomics market, by technique
8.4.2.16.India Single cell multiomics market, by end user
8.4.2.17.South Korea Single cell multiomics market, by type
8.4.2.18.South Korea Single cell multiomics market, by application
8.4.2.19.South Korea Single cell multiomics market, by technique
8.4.2.20.South Korea Single cell multiomics market, by end user
8.4.2.21.Rest of Asia-Pacific Single cell multiomics market, by type
8.4.2.22.Rest of Asia-Pacific Single cell multiomics market, by application
8.4.2.23.Rest of Asia-Pacific Single cell multiomics market, by technique
8.4.2.24.Rest of Asia-Pacific Single cell multiomics market, by end user
8.4.3.Asia-Pacific market size and forecast, by type
8.4.4.Asia-Pacific market size and forecast, by application
8.4.5.Asia-Pacific market size and forecast, by technique
8.4.5.1.Asia-Pacific single-cell isolation and dispensing, by application
8.4.5.2.Asia-Pacific single-cell analysis, by application
8.4.6.Asia-Pacific market size and forecast, by end user
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country
8.5.2.1.Brazil Single cell multiomics market, by type
8.5.2.2.Brazil Single cell multiomics market, by application
8.5.2.3.Brazil Single cell multiomics market, by technique
8.5.2.4.Brazil Single cell multiomics market, by end user
8.5.2.5.Saudi Arabia Single cell multiomics market, by type
8.5.2.6.Saudi Arabia Single cell multiomics market, by application
8.5.2.7.Saudi Arabia Single cell multiomics market, by technique
8.5.2.8.Saudi Arabia Single cell multiomics market, by end user
8.5.2.9.Rest of LAMEA Single cell multiomics market, by type
8.5.2.10.Rest of LAMEA Single cell multiomics market, by application
8.5.2.11.Rest of LAMEA Single cell multiomics market, by technique
8.5.2.12.Rest of LAMEA Single cell multiomics market, by end user
8.5.3.LAMEA market size and forecast, by type
8.5.4.LAMEA market size and forecast, by application
8.5.5.LAMEA market size and forecast, by technique
8.5.5.1.LAMEA single-cell isolation and dispensing, by application
8.5.5.2.LAMEA single-cell analysis, by application
8.5.6.LAMEA market size and forecast, by end user

CHAPTER 9:COMPANY PROFILES
9.1.BGI Genomics Co. Ltd.
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.Bio-Rad Laboratories, Inc.
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.Danaher Corporation (Cytiva Life sciences)
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments
9.4.Fluidigm Corporation
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.Illimina Inc.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.6.Mission Bio, Inc.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Key strategic moves and developments
9.7.NanoString Technologies, Inc
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.Qiagen N.V.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.Takara Holdings Inc. (Takara Bio Group)
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.10x Genomics, Inc.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments

List of Tables

TABLE 01.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02.SINGLE CELL GENOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03.SINGLE CELL PROTEOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04.SINGLE CELL TRANSCRIPTOMICSMARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05.SINGLE CELL METABOLOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 06.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030($MILLION)
TABLE 07.ONCOLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 08.CELL BIOLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 09.NEUROLOGY MARKET, BY REGION, 2020-2030($MILLION)
TABLE 10.OTHERS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 11.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030($MILLION)
TABLE 12.SINGLE-CELL ISOLATION AND DISPENSING MARKET, BY REGION, 2020-2030($MILLION)
TABLE 13.SINGLE-CELL ISOLATION AND DISPENSING, BY APPICATION, 2020-2030 ($MILLION)
TABLE 14.SINGLE-CELL ANALYSIS MARKET, BY REGION, 2020-2030($MILLION)
TABLE 15.SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 16.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 17.ACADEMIC INSTITUTES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 19.PHARMACEUTICAL AND BIOTECH COMPANIES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 20.GLOBAL SINGLE CELL MULTIOMICS MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 21.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 22.U.S. SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 23.U.S. SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 24.U.S SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 25.U.S. SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 26.CANADA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 27.CANADA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 28.CANADA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 29.CANADA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 30.MEXICO SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 31.MEXICO SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 32.MEXICO SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 33.MEXICO SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 34.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 35.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 36.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 37.NORTH AMERICA SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 38.NORTH AMERICA SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 39.NORTH AMERICA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 40.EUROPE SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 41.GERMANY SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 42.GERMANY SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 43.GERMANY SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 44.GERMANY SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 45.FRANCE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 46.FRANCE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 47.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 48.FRANCE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 49.UK SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 50.UK SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 51.UK SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 52.UK SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 53.ITALY SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 54.ITALY SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 55.ITALY SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 56.ITALY SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 57.SPAIN SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 58.SPAIN SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 59.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 60.SPAIN SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 61.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 62.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 63.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 64.REST OF EUROPE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 65.EUROPE SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 66.EUROPE SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 67.EUROPE SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 68.EUROPE SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 69.EUROPE SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 70.EUROPE SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 71.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 72.JAPAN SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 73.JAPAN SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 74.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 75.JAPAN SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 76.CHINA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 77.CHINA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 78.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 79.CHINA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 80.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 81.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 82.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 83.AUSTRALIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 84.INDIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 85.INDIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 86.INDIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 87.INDIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 88.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 89.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 90.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 91.SOUTH KOREA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 92.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 93.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 94.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 95.REST OF ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 96.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 97.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 98.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 99.ASIA-PACIFIC SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 100.ASIA-PACIFIC SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 101.ASIA-PACIFIC SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 102.LAMEA SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 103.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 104.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 105.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 106.BRAZIL SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 107.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 108.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 109.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 110.SAUDI ARABIA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 111.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 112.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 113.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 114.REST OF LAMEA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 115.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TYPE, 2020-2030
TABLE 116.LAMEA SINGLE CELL MULTIOMICS MARKET, BY APPLICATION, 2020-2030
TABLE 117.LAMEA SINGLE CELL MULTIOMICS MARKET, BY TECHNIQUE, 2020-2030
TABLE 118.LAMEA SINGLE-CELL ISOLATION AND DISPENSING, BY APPLICATION, 2020-2030
TABLE 119.LAMEA SINGLE-CELL ANALYSIS, BY APPLICATION, 2020-2030
TABLE 120.LAMEA SINGLE CELL MULTIOMICS MARKET, BY END USER, 2020-2030
TABLE 121.BGI GENOMICS: COMPANY SNAPSHOT
TABLE 122.BGI GENOMICS: PRODUCT PORTFOLIO
TABLE 123.BGI GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 124.BIO-RAD: COMPANY SNAPSHOT
TABLE 125.BIO-RAD: OPERATING SEGMENTS
TABLE 126.BIO-RAD: PRODUCT PORTFOLIO
TABLE 127.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128.DANAHER: COMPANY SNAPSHOT
TABLE 129.DANAHER: OERATING SEGMENT
TABLE 130.DANAHER: PRODUCT PORTFOLIO
TABLE 131.DANAHER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132.FLUIDIGM: COMPANY SNAPSHOT
TABLE 133.FLUIDIGM: OPERATING SEGMENTS
TABLE 134.FLUIDIGM: PRODUCT PORTFOLIO
TABLE 135.FLUIDIGM: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136.ILLUMINA: COMPANY SNAPSHOT
TABLE 137.ILLUMINA: OERATING SEGMENT
TABLE 138.ILLUMINA: PRODUCT PORTFOLIO
TABLE 139.MISSION BIO: COMPANY SNAPSHOT
TABLE 140.MISSION BIO: OPERATING SEGMENTS
TABLE 141.MISSION BIO: PRODUCT PORTFOLIO
TABLE 142.MISSION BIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 143.NANOSTRING TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 144.NANOSTRING TECHNOLOGIES: OPERATING SEGMENTS
TABLE 145.NANOSTRING TECHNOLOGIES: PRODUCT PORTFOLIO
TABLE 146.NANOSTRING TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 147.QIAGEN: COMPANY SNAPSHOT
TABLE 148.QIAGEN: OERATING SEGMENT
TABLE 149.QIAGEN: PRODUCT PORTFOLIO
TABLE 150.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 151.TAKARA HOLDINGS: COMPANY SNAPSHOT
TABLE 152.TAKARA HOLDINGS: PRODUCT PORTFOLIO
TABLE 153.TAKARA HOLDINGS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 154.10X GENOMICS: COMPANY SNAPSHOT
TABLE 155.10X GENOMICS: OERATING SEGMENT
TABLE 156.10X GENOMICS.: PRODUCT PORTFOLIO
TABLE 157.10X GENOMICS: KEY STRATEGIC MOVES AND DEVELOPMENTS

List of Figures

FIGURE 01.GLOBAL SINGLE CELL MULTIOMICS MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF SINGLE CELL PROTEOMICSMARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF BANDAGE SINGLE CELL PROTEOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF SINGLE CELL TRANSCRIPTOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF SINGLE CELL METABOLOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF ONCOLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF CELL BIOLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF NEUROLOGY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF OTHERS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF SINGLE-CELL ISOLATION AND DISPENSING MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.ONCOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 23.CELL BIOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 24.NEUROLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 25.OTHERS MARKET, 2020-2030 ($MILLION)
FIGURE 26.COMPARATIVE ANALYSIS OF SINGLE-CELL ANALYSIS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 27.ONCOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 28.CELL BIOLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 29.NEUROLOGY MARKET, 2020-2030 ($MILLION)
FIGURE 30.OTHERS MARKET, 2020-2030 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF HOSPITAL AND CLINIC SINGLE CELL MULTIOMICS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF CONTRACT RESEARCH ORGANIZATIONS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 33.COMPARATIVE ANALYSIS OF PHARMACEUTICAL AND BIOTECH COMPANIES MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 34.BGI GENOMICS: NET SALES, 2018-2020 ($MILLION)
FIGURE 35.BIO-RAD: NET SALES, 2018-2020 ($MILLION)
FIGURE 36.BIO-RAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.BIO-RAD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.DANAHER: NET SALES, 2018-2020 ($MILLION)
FIGURE 39.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 40.DANAHER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 41.FLUIDIGM: NET SALES, 2018-2020 ($MILLION)
FIGURE 42.FLUIDIGM: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.ILLUMINA: NET SALES, 2018-2020 ($MILLION)
FIGURE 44.ILLUMINA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 45.NANOSTRING TECHNOLOGIES: NET SALES, 2018-2020 ($MILLION)
FIGURE 46.10X GENOMICS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 47.QIAGEN: NET SALES, 2018-2020 ($MILLION)
FIGURE 48.QIAGEN: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 49.TAKARA HOLDINGS: NET SALES, 2018-2020 ($MILLION)
FIGURE 50.TAKARA HOLDINGS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 51.10X GENOMICS: NET SALES, 2018-2020 ($MILLION)
FIGURE 52.10X GENOMICS: REVENUE SHARE BY REGION, 2020 (%)

Companies Mentioned
Bio-Rad Laboratories (Celsee, Inc.), BGI Genomics Co. Ltd., Cytiva Life Science (Previously GE), Fluidigm Corporation, Illumina, Inc., 10x Genomics, NanoString Technologies, MissionBio, QIAGEN N.V., and Takara Bio.